Protara Therapeutics Inc (NASDAQ: TARA) on Tuesday, soared 18.32% from the previous trading day, before settling in for the closing price of $4.53. Within the past 52 weeks, TARA’s price has moved between $2.21 and $10.48.
Healthcare Sector giant saw their annual sales surged by 55.31% over the last five years. The company achieved an average annual earnings per share of 40.17%. With a float of $33.99 million, this company’s outstanding shares have now reached $38.59 million.
Protara Therapeutics Inc (TARA) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Protara Therapeutics Inc is 11.89%, while institutional ownership is 71.66%. The most recent insider transaction that took place on May 14 ’25, was worth 63,800. In this transaction Director of this company bought 20,000 shares at a rate of $3.19, taking the stock ownership to the 51,000 shares. Before that another transaction happened on Mar 26 ’25, when Company’s Chf Scientific Operations Off sold 21,224 for $4.53, making the entire transaction worth $96,145. This insider now owns 98,861 shares in total.
Protara Therapeutics Inc (TARA) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.43 earnings per share (EPS) for the period topping the consensus outlook (set at -0.56) by 0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 40.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.56% during the next five years compared to 55.31% growth over the previous five years of trading.
Protara Therapeutics Inc (NASDAQ: TARA) Trading Performance Indicators
Protara Therapeutics Inc (TARA) is currently performing well based on its current performance indicators. A quick ratio of 13.69 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.44, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Protara Therapeutics Inc (TARA)
Analysing the last 5-days average volume posted by the [Protara Therapeutics Inc, TARA], we can find that recorded value of 0.46 million was better than the volume posted last year of 0.37 million. As of the previous 9 days, the stock’s Stochastic %D was 47.44%.
During the past 100 days, Protara Therapeutics Inc’s (TARA) raw stochastic average was set at 82.22%, which indicates a significant decrease from 95.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.42, while its 200-day Moving Average is $3.79. Now, the first resistance to watch is $5.69. This is followed by the second major resistance level at $6.01. The third major resistance level sits at $6.61. If the price goes on to break the first support level at $4.77, it is likely to go to the next support level at $4.17. Now, if the price goes above the second support level, the third support stands at $3.85.
Protara Therapeutics Inc (NASDAQ: TARA) Key Stats
Market capitalization of the company is 206.83 million based on 38,582K outstanding shares. Right now, sales total 0 K and income totals -44,600 K. The company made 0 K in profit during its latest quarter, and -14,960 K in sales during its previous quarter.
